Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADOLIMIS: Emotional Regulation in Adolescents with BPD
NCT03209102Phase 2Active, not recruiting
- Sponsor
- Inserm
- Start
- Oct 2017
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Phase 2, open-label trial (2 arms), sponsored by Inserm. Primary endpoints: Comparison between subjective and objective acute stress experience up to 3 months and Neural correlates and modulation of motivation and impulsivity up to 3 months. Started Oct 2017; status: active, not recruiting.
Beyond the preview
Go deeper on NCT03209102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03209102.